We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Carcinoma-Associated Hemolytic-Uremic Syndrome in a Patient receiving 5-Fluorouracil-Adriamycin-Mitomycin C Combination Chemotherapy.
- Authors
Mergenthaler, H.-G.; Binsack, Th.; Wilmanns, W.
- Abstract
A patient receiving the antitumor agent mitomycin C (MMC) in combination with 5-fluorouracil and adriamycin because of adenocarcinoma of Vater's papilla manifested hemolytic-uremic syndrome (HUS) after five cycles of 5-fluorouracil-adriamycin-MMC combination chemotherapy. The syndrome most likely was caused by MMC, since an association between HUS and the use of MMC has been observed. We report on the clinical course in such a patient and review the pertinent literature. Copyright © 1988 S. Karger AG, Basel
- Publication
Oncology, 1988, Vol 45, Issue 1, p11
- ISSN
0030-2414
- Publication type
Article
- DOI
10.1159/000226521